Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Rani Soenen

Work address: C. Heymanslaan 10, ingang 12 - verdieping 13
9000 Gent
Email: Rani.Soenen@UGent.be
ORCID iD: 0000-0002-7625-6630

Show Sort by

Add to list
- PhD Thesis
Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making

Rani Soenen (UGent)

(2023)
Add to list
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Rani Soenen (UGent) , Christophe Stove (UGent) , Alessio Capobianco, Hanne De Schutter, Marie Dobbelaere, Tahmina Mahjor, Merel Follens, Jo Lambert (UGent) and Lynda Grine (UGent)

(2022) JOURNAL OF CLINICAL MEDICINE. 11(11).
Add to list
- Journal Article
- A1
- open access
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Rani Soenen (UGent) , Zhigang Wang, Lynda Grine (UGent) , Erwin Dreesen, Lisa Schots (UGent) , Els Brouwers, Paul Declerck, Debby Thomas and Jo Lambert (UGent)

(2022) CLINICAL AND EXPERIMENTAL DERMATOLOGY. 47(7). p.1324-1336
Add to list
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey

Lisa Schots (UGent) , Lynda Grine (UGent) , Rani Soenen (UGent) and Jo Lambert (UGent)

(2022) JOURNAL OF DERMATOLOGICAL TREATMENT. 33(3). p.1473-1481
Add to list
- Journal Article
- A2
- open access
Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Pierre-Dominique Ghislain, Valérie Failla, Jo Lambert (UGent) , Rani Soenen (UGent) , Lynda Grine (UGent) , Julio Tannous, Françoise Guiot, Fabienne Willaert, Hugues Fierens, Mark Vandaele, et al.

(2021) JAAD INTERNATIONAL. 4. p.15-17
Add to list
- Journal Article
- A1
- open access
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Nathalie Van den Berghe, Aurélie Truffot, Miet Peeters, Griet Compernolle, Els Brouwers, Rani Soenen (UGent) , Lynda Grine (UGent) , Ann Gils and Maya Imbrechts

(2020) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 189.
Add to list
Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study

F. Benhadou, PD. Ghislain, F. Guiot, F. Willaert, V. Del Marmol, Jo Lambert (UGent) , Rani Soenen (UGent) , H. Fierens and M. de la Brassinne

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(12). p.E837-E839
Add to list
- Journal Article
- A1
- open access
Clinical response correlates with 4-week postinjection ustekinumab concentrations in patients with moderate-to-severe psoriasis

N. Van den Berghe, Eline De Keyser (UGent) , Rani Soenen (UGent) , L. Meuleman, S. Lanssens, A. Gils and Jo Lambert (UGent)

(2020) BRITISH JOURNAL OF DERMATOLOGY. 182(2). p.390-397
Add to list
- Journal Article
- A1
- open access
Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter (UGent) , Lynda Grine (UGent) , Nathalie Van den Berghe, Els Brouwers, Reinhart Speeckaert (UGent) , Sven Lanssens, Linda Temmerman, Jo Lambert (UGent) and Ann Gils

(2019) JOURNAL OF INVESTIGATIVE DERMATOLOGY. 139(10). p.2232-2235
Add to list
- Conference Paper
- C3
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani Soenen (UGent) , Evelyn Meulewaeter (UGent) , Lynda Grine (UGent) , Linda Temmerman (UGent) , Sven Lanssens, Els Brouwers, Nathalie Van den Berghe, Reinhart Speeckaert (UGent) , Jo Lambert (UGent) and Ann Gils

(2019) 24th World Congress of Dermatology, Abstracts.

1
2

Next →